Possible mechanisms include upregulation of insulin-like growth factor-1 (which has a higher mitogenic and antiapoptotic potency than insulin) via hyperglycemia and hyperinsulinemia, as well as higher levels of proinflammatory factors under chronic inflammation [2, 45]. The gene discussed is INS; the disease is hyperinsulinism.